Columbus, OH · Founded 2019 · Privately Held (backing)
Developer of immune-facilitated biologic therapies designed to fight life-threatening infections. Clarametyx Biosciences is based in Columbus, OH and was founded in 2019. It was valued at $92 million at its later-stage round in Jul 2025, the last priced event on record. It has raised $44 million across 1 recorded round; the latest was a $27.5 million early-stage round in Jan 2024.
PMV mark · valuation
$92.0M
Oct 2026
Priced at
its later-stage round
Jul 2025
Total raised
$44.0M
Last round
Early Stage VC
Jan 2024
Cap table — not yet on record
Clarametyx Biosciences's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Clarametyx Biosciences with a free account
·Watch Clarametyx Biosciences: the Monday email on marks, rounds and moves
Where does Clarametyx Biosciences's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Clarametyx Biosciences's 1 recorded funding rounds.
